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Summary 
MHC class II molecules play a fundamental role in the cellular immune system: they load short 
peptide fragments derived from extracellular proteins and present them on the cell surface. It is 
currently thought that the peptide binds lying more or less flat in the MHC groove, with a fixed 
distance of nine amino acids between the first and last residue in contact with the MHCII. While 
confirming that the great majority of peptides bind to the MHC using this canonical mode, we 
report evidence for an alternative, less common mode of interaction. A fraction of observed 
ligands were shown to have an unconventional spacing of the anchor residues that directly 
interact with the MHC, which could only be accommodated to the canonical MHC motif either by 
imposing a more stretched out peptide backbone (a 8mer core) or by the peptide bulging out of 
the MHC groove (a 10mer core). We estimated that on average 2% of peptides bind with a core 
deletion, and 0.45% with a core insertion, but the frequency of such non-canonical cores was as 
high as 10% for certain MHCII molecules. A mutational analysis and experimental validation of a 
number of these anomalous ligands demonstrated that they could only fit to their MHC binding 
motif with a non-canonical binding core of length different from nine. This previously 
undescribed mode of peptide binding to MHCII molecules gives a more complete picture of 
peptide presentation by MHCII and allows us to model more accurately this event. 
 
 
Introduction 
The primary function of class II major histocompatibility complex molecules (MHCII) is to alert 
the immune system to the presence of a pathogen by binding and presenting short peptide 
fragments derived from exogenously derived proteins. Once outside the cell, T helper 
lymphocytes bearing receptors specific for the peptide-MHCII complex can recognize the 
peptide as non-self and help initiating an appropriate immune response (1–3). Structurally, 
MHCII consists of two non-covalently bound amino acid chains, the α and the β chain. The two 
domains α1 and β1 of these chains combine to form the peptide-binding groove. Because the 
MHCII groove is open at the extremities, the peptide ligand can freely extend outside both ends. 
The stretch of peptide residues directly interacting with the groove, the so-called binding core, 
is the main determinant of peptide binding to MHCII. Ample structural data show that the 
peptide binds lying flat in the groove, with an extended conformation and a fixed distance of 
typically nine amino acids between the first and last peptide residue in contact with the MHCII 
groove (4). The residues at positions P1, P4, P6 and P9 of the binding core, termed anchor 
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residues, are normally directed towards the MHC, and they can engage in interactions with 
pockets in the binding groove. As the α1 and β1 chains are highly polymorphic, the preferences 
of these pockets in terms of which residues they can accommodate can vary greatly. As a 
consequence, different MHCII alleles bind distinct subsets of peptides (5). 
 
In contrast to MHCII, the binding groove of class I MHC molecules (MHCI) is closed at both ends, 
with most binding peptides having a length of nine amino acids. Longer peptides are 
accommodated either by taking on a bulged conformation with the middle of the peptide 
protruding out of the MHC groove (6), or less frequently by extending outside the C or N 
terminals (7,8). Peptides of length eight can also bind to the MHCI, by assuming a more 
stretched configuration of the backbone (3). We have shown with the most recent versions of 
NetMHC (9) and NetMHCpan (10) that these alternative modes of binding could be modeled 
with deletions and insertions in the binding core of the peptide. Deletions allow removing 
consecutive residues in peptides longer than nine amino acids to effectively align 10mers, 
11mers, etc. to the same binding core of nine positions. Ideally, the deleted positions represent 
the residues that bulge out of the MHCI groove, whereas an insertion mimics a more stretched-
out backbone and adapts 8mers to the common window of nine residues. This strategy has 
proven highly successful for MHCI binding prediction as it allows training models on peptides of 
all lengths at the same time, resulting in improved performance for all peptide lengths (9). 
NetMHCIIpan is a widely used computational method that can predict quantitative binding of 
peptides to any MHCII molecule of known sequence. In several benchmarks, it has been shown 
to be the state-of-the-art for the prediction of peptide binding to MHC class II (11–13). Similarly 
to the methods for peptide-MHC class I binding prediction NetMHC and NetMHCpan discussed 
above, the algorithm underlying NetMHCIIpan relies on the neural networks training pipeline 
NNAlign (14,15).  One major challenge faced when training machine learning methods for the 
prediction of peptide binding to MHCII stems from the open binding cleft of the MHCII molecule. 
This open conformation makes the location of the binding core within the peptide unknown a 
priori. Because the peptide binding core is the main determinant of the interaction with the 
MHC molecule, correct alignment of peptides is essential to identify the MHCII binding motifs. 
The NNAlign method allows for such accurate alignment based on quantitative peptide-MHC 
binding affinity (14). It does so by encoding the amino acid sequence of the peptide and of the 
MHC and several other features of the training examples (e.g. peptide length, peptide flanking 
region (PFR) composition and PFR length) to predict quantitative measurements of peptide-
MHC binding affinity.  
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In this work, we applied the extended NNAlign pipeline (version 2.0) including modes for 
deletions and insertions, allowing us to model the peptide-MHC class II binding event with cores 
of variable length. In the context of MHCII, binding cores with insertions and deletions would 
indicate a non-canonical mode of binding with either a bulged or stretched configuration of the 
peptide in the binding groove. We assessed the predictive performance of the method on 
several datasets, and carried out mutational studies to validate the occurrence of non-canonical 
binding cores of length different from nine. 
 
Materials and Methods 
Data Sets 
The method was trained on the binding data used in the NetMHCIIpan-3.0 publication (16) 
(available at http://www.cbs.dtu.dk/suppl/immunology/NetMHCIIpan-3.0). This set consists of 
quantitative peptide-MHC class II binding data from the Immune Epitope Database (IEDB) (17), 
comprising 52,062 affinity measurements covering 24 HLA-DR, 5 HLA-DP, 6 HLA-DQ, and 2 
murine H-2 molecules. The IC50 (half inhibitory concentration) values in nanomolar were 
transformed using the logarithmic formula 1-log(IC50)/log(50,000) as previously described 
(18) to make them fall in the range between 0 and 1. 
 
Training the Artificial Neural Networks 
The method was implemented as an ensemble of feed-forward neural networks with a single 
hidden layer as previously described (19). Peptide and MHC sequences were presented to the 
input layer of each network using BLOSUM encoding, where each amino acid was encoded as 
the BLOSUM50 matrix score vector of 20 amino acids (20). The optimal 9-mer core of a peptide 
therefore required 9 × 20 = 180 input neurons. Deletions and insertions were encoded as 
previously described (9) : cores longer than nine amino acids were reduced to nine positions by 
applying consecutive deletions at all possible positions in the core; cores shorter than nine were 
completed by introducing the wildcard X amino acid, encoded as a vector of zeros. The length of 
insertions Li and deletions Ld was encoded with four input neurons with values Li/(Li+1), 1-
Li/(Li+1), Ld/(Ld+1) and 1-Ld/(Ld +1). Forty additional input neurons were used to encode the 
composition of the peptide flanking regions (PFRs), calculated as the average BLOSUM scores 
on a maximum window of three amino acids at either end of the binding core (19). C- and N-
terminal PFR lengths (LPFR) were each encoded using two input neurons with values LPFR /(LPFR 
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+ 1) and 1-LPFR/(LPFR + 1) respectively. The peptide length L was encoded with two input 
neurons taking the values LPEP and 1-LPEP, where LPEP  = 1/(1 + exp((15-L)/2)). These 
transformations ensure that the normalized input values to the neural networks fall in the range 
between 0 and 1. MHC molecules were represented in terms of a pseudo-sequence defined by 
polymorphic residues in potential contact with a bound peptide (21). We used the same 
pseudo-sequences of 34 residues for the MHC alpha and beta chains defined by Karosiene et al. 
(16), resulting in additional 34 × 20 = 680 inputs. As a result, the total size of the input layer 
amounted to 910 neurons. 
 
The single hidden layer was composed of 10, 15, 40, or 60 hidden neurons, and network 
weights were initialized with 10 different random configurations for each architecture. The 
resulting complete ensemble was therefore composed of 200 networks (5 cross-validation folds 
x 4 hidden layer sizes x 10 initial weights). The output layer was composed of a single neuron 
having as target value the binding affinity of the training example rescaled between 0 and 1 as 
described in the section Data sets. When allowing insertions and/or deletions, networks were 
trained using a burn-in period, a number of initial iterations where insertions and deletions 
were not allowed. After the burn-in, this constraint is relaxed and the algorithm starts 
attempting to introduce insertions/deletions as well. 
 
Cross-Validation Subsets 
The performance of the method on the binding affinity data set was performed using a 5-fold 
cross-validation, where four fifths of the data were used for training and one fifth for evaluation, 
repeating the procedure five times for all evaluation fifths. We used the same data partitions 
that had been generated to train NetMHCIIpan-3.0 (16). In order to minimize over-estimation of 
predictive performance, these subsets for cross-validation were created using a Hobohm1-like 
algorithm called "common-motif" (22). Common-motif first selects seed sequences sharing at 
most a continuous stretch of eight amino acids, and then splits these seed sequence randomly 
into five partitions. The redundant sequences, i.e. those peptides with a common subsequence 
of nine or more contiguous amino acids, are then added to the group containing the seed used to 
define their redundancy. 
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Reduced Subsets with Minimal Redundancy 
Although the procedure outlined above reduces the overlap between partitions compared to a 
random split of the data, some degree of overlap is unavoidable without removing data points. 
We constructed a reduced data set that ensures no overlap between the partitions. The 
algorithm to create the subsets starts with a prioritized list of sequences, sorted by the number 
of MHCs that each peptide is measured in complex with. That is, we start with peptides that 
have affinity measurements with the largest number of MHCs and proceed to accept or reject 
sequences based on their similarity to the ones that were already accepted. As we proceed 
down the list of sequences, there are three possible outcomes for a query sequence Q: 
 
1) Q shares no contiguous stretch >= N amino acids with any of the accepted peptides; it is 
accepted and assigned randomly to one of the subsets. 
2) Q shares a contiguous stretch >= N amino acids only to sequences of one subset S; it is 
accepted and placed in the subset S. Note that it can match to several sequences, but as long as 
they all belong to the same subset, it is still accepted. 
3) Q shares a contiguous stretch >= N amino acids to sequences belonging to more than one 
subset; the peptide is discarded. 
 
Starting with a prioritized list aims at removing as few sequences as possible while at the same 
time ensuring no overlap >= N amino acids between the subsets. 
 
Statistical Tests 
The predictive performances of alternative methods were compared using binomial tests. Given 
a pair of methods, the null hypothesis is that the two methods have equal probability of 
returning higher PCC (or AUC) on a given MHC allele. If method 1 has higher PCC in n1 alleles 
and method 2 higher PCC in n2 alleles, we estimated the p-value of this event as the two-tailed 
probability of observing n1 or more wins by chance in a binomial distribution B(n1 + n2, 0.5). 
Ties were excluded from the counts of n1 and n2. 
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Measurement of MHC/Peptide Interactions by Monoclonal Antibody Capture 
The binding capacity of peptide ligands to bind MHC molecules was measured using direct and 
quantitative binding assays as previously described elsewhere (23). In brief, inhibitor peptides 
to be tested were prepared at 10 mg/mL in 100% DMSO and subsequently diluted to desired 
concentration in 0.05% NP-40 (0.05% (v/v) Nonidet P-40 (NP-40; Fluka)/PBS, pH 7.2). Then, 
5µL of each peptide dose were loaded into a 96-well plate. For positive (i.e. no inhibitor 
peptide) and negative (no MHC) controls 5µL 0.05% NP-40 was used. For each plate, an 
unlabeled standard peptide (i.e. peptide with known IC50 for the tested MHC) was used. Next, 
radioactive labeled standard peptide (for labeling procedure refer to Support Protocol 2 (23)) 
was mixed with PBS (pH 7.2), MHC, protease inhibitor cocktail and either 1.6% (v/v) NP-
40/PBS or 0.82% Pluronic to make reaction mix (hot mix). For plate layouts and exact amounts 
of ingredients used in this assay, please refer to Sidney et al (23) as they vary among different 
class II MHCs tested. 10µL of hot mix were immediately added to all wells but the negative 
control. For negative controls, 10µL of reaction mix lacking MHC (cold mix) were added. Next, 
96-well plates were sealed with Costar mats (Fisher Scientific, #07-200-614) and incubated 48h 
at room temperature (most assays). Alternatively, some assays required 72h of incubation 
and/or an incubation temperature of 37°C or MHC specific modifications, e.g. adjustment of 
final pH to optimize reactions (23). Finally, MHC/peptide complexes were captured utilizing 
monoclonal antibody-coated plates (Support protocol 4 (23)) and IC50 were determined using 
the Topcount (PerkinElmer Instruments) benchtop microplate scintillation and luminescence 
counter.  
 
Results 
Modeling peptide binding to MHCII, and particularly which peptide residues are implicated in 
the interaction, requires an alignment of the peptide sequences. We investigated whether, 
allowing the peptide alignment to contain insertions and deletions, we could generate better 
prediction models compared to what could be obtained with an un-gapped alignment, and 
experimentally validated the binding mode of a set of peptides predicted to contain non-
canonical binding cores.  
Priming Neural Networks with a Burn-In Period 
When expanding the mode of binding cores to include insertions and deletions, the solutions 
space becomes substantially larger. For instance, there are seven possible un-gapped 9mer 
cores in a 15mer peptide, but there are 45 possible 10mers with one deletion, and 56 possible 
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8mers with one insertion. The abundance of possible core configurations makes it likely that a 
naive network will get lost in local minima mainly composed of these non-9mer cores. To avoid 
this, we introduced a burn-in period, in which a number of initial iterations in neural network 
training were performed without allowing for insertions and deletions. The burn-in period has 
the function of guiding the neural networks onto the right path, using the prior knowledge that 
9mer cores should be the norm and that cores with insertions/deletions are the exception. 
 
We trained neural networks on the binding affinity data set (see Materials and Methods) with 
and without insertions/deletions, and with different burn-in periods. The method without 
insertions/deletions can be thought of as having a burn-in period equal to the total number of 
training iterations, and is essentially equivalent to the NetMHCIIpan-3.0 method (16). 
 
It is evident from Figure 1 that the burn-in iterations are crucial to drive neural network 
learning: training without this initial priming (burn-in=0) did not improve the performance 
compared to the method trained without insertions and deletions, termed NoGap in Figure 1 
(p=0.26, two-tailed binomial test). With an appropriate burn-in rate (around 50-150 out of 500 
total iterations) and a maximum length for deletions and insertions of one amino acid, we 
observed an average improvement in predictive performance in a cross-validation setup (Figure 
1). The increase in Pearson Correlation Coefficient (PCC) compared to NoGap was significant, 
with higher performance observed on 34/37 molecules with burn-in=100 (p=10-7, two-tailed 
binomial test). Similarly, when we evaluated predictive performance in terms of AUC, the 
method with insertions/deletions outperformed NoGap on 33 out of 37 molecules (p=10-6), 
with average AUC=0.875 compared to 0.870 of the NoGap method. The method trained with at 
most one deletion and one insertion also outperformed neural networks trained with at most 
one deletion and no insertions (p=10-7), and networks allowing no more than one insertion and 
no deletions (p=10-6). Allowing longer deletions of up to 2 amino acids did not further improve 
cross-validated performance (p=0.32). Figure 2 summarizes these comparisons. 
 
Insertions and Deletions are Relatively Rare and Allele-Specific  
In order to estimate the frequency of the deletion and insertion events, we submitted 3.7 million 
(100,000 for each of the 37 molecules in the data set) random natural 15mer peptides to the 
neural networks. Defining peptides within the top 10th percentile as binders, we find that 2.0% 
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of the binders were predicted to contain a core deletion, and 0.45% presented an insertion. 
However, we observed that certain molecules had stronger preferences for insertions/deletions 
whereas they were never predicted to occur in others (Figure 3). For example, even with a 
relatively conservative burn-in of 100 iterations, DRB3*01:01 and DRB5*01:01 had more than 
10% of their predicted binders with an optimal 8- or 10-amino acids core. Conversely, all HLA-
DP and HLA-DQ showed less than 1% of predicted binders with non-canonical cores. The mouse 
molecules H-2-IAb and H-2-IAd also had a very low fraction of insertions/deletions. The profiles 
of insertion and deletion frequencies for different values of the burn-in rate are shown in Figure 
S1.  
 
Data Redundancy and Its Effect on Cross-Validated Performance 
The data partitions used to train NetMHCIIpan-3.0 in cross-validation were generated using a 
common-motif procedure (described in Materials and Methods and in ref. (22)), which aimed at 
limiting the sequence similarity between partitions. Although this procedure reduces the 
overlap between partitions compared to a random split of the data, some degree of sequence 
similarity is unavoidable without removing data points. Indeed, on the binding affinity data set, 
after applying the common-motif, 45% of the sequences still shared a continuous stretch >= 9 
amino acids with at least one other sequence in a different partition. Such redundancy can lead 
to overestimating the predictive performance in cross-validation (24), as these examples are 
relatively easy to predict - the neural networks have seen a very similar example in the training 
phase. Over-estimation of the predictive performance is expected to be more pronounced for 
methods with larger search spaces and model parameters. Therefore, one may argue that the 
gain in performance obtained by including deletions and insertions could be an artifact of data 
redundancy and of the increase in model complexity.   
 
To investigate this, we generated reduced data sets that ensured no overlap >= N contiguous 
amino acids between any sequence in different cross-validation subsets, applying the algorithm 
described in Materials and Methods. Depending on the length of the common-motif threshold N, 
a different number of sequences must be removed from the data set to fulfill the no-overlap 
condition. Figure 4 shows the percentage of removed sequences depending on N. For common-
motif lengths 3-5, as expected, the number of removed peptides decreases when considering 
longer cores. However, the number of peptides removed for lengths 6-10 is essentially the same 
(about 14-15% of the sequences). This is likely due to a significant fraction of peptides tested 
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for binding being generated as 15-mers overlapping by 10 residues, which is a common 
approach to cover an antigen of interest (25,26). Therefore, for a more stringent reduction of 
redundancy (without losing any extra data), we continued the analysis using N=6. In other 
words, we removed about 7,800 sequences of the 52,062 in the training set, ensuring that no 
two sequences across subsets shared more than 5 consecutive amino acids. Approximately the 
same number of peptides would have to be removed to ensure a maximum overlap of 8 (N=9).  
 
The MHCII-peptide binding predictor was retrained on these reduced partitions, both with and 
without insertions/deletions. As expected, the cross-validated performance on the data set 
without overlap between partitions drops significantly (p=10-8) compared to the method 
trained on all data, as all the evaluation examples now have a lower degree of similarity to the 
training data. However, even in this extreme scenario, the performance of the method remains 
high with average PCC values in the order of 0.7 for all burn-in rates (Figure 5). More 
importantly, we observed also on these data that the method with insertions/deletions 
performs significantly better than the NoGap counterpart, with higher PCC for 31/37 molecules 
(p=4*10-5) with a burn-in rate = 100. This demonstrates that the prediction of peptides with 
non-canonical binding cores was not merely a result memorized by the neural networks as 
outliers, and that the rules of placing insertions/deletions could be generalized and applied on a 
set of peptide sequences very different from the ones used to train the networks. 
 
A Mutational Analysis Supports the Hypothesis of 10mer Binding Cores 
In order to validate experimentally the occurrence of binding cores with length different from 
nine amino acids, we designed a number of mutations to four validated MHCII binding peptides. 
The four wild type (WT) peptides in Figure 6 were all predicted to contain a 10mer binding core 
(i.e. they comprised a deletion). In all four cases, the canonical and non-canonical predicted 
cores agree on the location of one anchor, and disagree on the position of a second anchor 
residue. 
 
The canonical binding motif for DRB1*03:01 has anchors at P1 with preference for hydrophobic 
amino acids, and at P4 with a preference for D (see Figure 6). Both DRB1*03:01 binders fail to 
match this motif, as the D at P4 is separated by four residues from the nearest hydrophobic 
amino acid. Two explanations for this inconsistency are possible: the P1 anchor can tolerate 
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non-hydrophobic amino acids, or the distance between P1 and P4 can be different from three 
amino acids. In the second scenario, we would predict that: 1) mutating the D at P4 to a 
dissimilar amino acid should abolish binding; 2) mutating the putative non-canonical P1 to a 
non-hydrophobic amino acid should also remove binding; 3) mutating the putative P1 of the 
9mer core should not affect binding; 4) additional mutations outside of the predicted core 
should not have an effect on binding. 
 
The binding motif for DRB5*01:01 has a strong hydrophobic anchor at P1, and a strong 
positively charged anchor at P9 (see Figure 6). Both binders are inconsistent with this motif, as 
the distance between the P1 and P9 in both cases is of ten residues. If these peptides interact 
with the MHCII with a binding core of ten amino acids, we would predict that: 1) mutating the F 
at P1 to a dissimilar amino acid should abolish binding; 2) mutating the P1+9 residue (i.e. the 
last residues in the predicted 10mer core) should prevent binding; 3) mutating the P1+8 
residue (i.e. the last residue in a putative 9mer core) should not affect binding; 4) mutations 
outside of the predicted core(s) should not have an effect on binding. 
 
The effects of targeted mutations on the four peptides are listed in Table 1. In most cases the 
measured IC50 affinity of the variants supports the presence of a 10mer binding core. Mutations 
on anchors of the 10mer cores abolished binding, whereas mutated anchors according to a 
putative 9mer core did not affect binding affinity compared to the WT. Therefore, successful 
binding for these peptides requires both anchor residues, and these are separated by a number 
of residues that is only consistent with a 10mer binding core. While the size of the effect was not 
identical for all mutations, the direction of the change in binding strength was consistent. For 
instance, peptide ISFCNANPGLMKDVA was measured to bind with affinity of 12nM to HLA-
DRB5*01:01, a value that ranks this sequence among the top 1.2% of predicted binders when 
compared to NetMHCIIpan prediction scores for a large set of random natural 15mer peptides. 
However, the measured affinity of the two mutants P3F>K (522 nM) and P12K>G (599nM) 
translate into respectively 35% and 38% in terms of such percentile ranks; in this light, the two 
mutations had a very severe effect on the strength of the interaction. 
The nearly three-fold reduction in binding affinity for the P4H>G mutant of MYFHKRDMRLLSLAV 
was somehow surprising, as the histidine at the predicted P2 of the core is not expected to play 
a determinant role in the binding capability of the peptide. However, glycine is a special amino 
acid since it only has a single hydrogen atom as its side chain. This small side chain grants high 
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flexibility to the polypeptide chain, and glycine can therefore have rotations angles forbidden by 
most other amino acids. The mutation H->G could impose structure variations in the peptide 
conformation not captured by the prediction method.  This said, the mutations at the predicted 
P1 and P4 of the binding core (P3F>A and P7D>V, respectively) have much more dramatic 
effects on the measured IC50, pointing to the dominant role of these two residues in 
determining the peptide-MHC interaction. Much more unexpected was the outcome for the 
P8D>V variant of LQIIDKIDAAFKVAA, which turned out as a binder (IC50=59nM) despite losing 
the aspartic acid (D) at the P4 anchor of the binding core (highlighted in bold). The NNAlign 
network ensemble predicts that the P8D>V mutant LQIIDKIVAAFKVAA has affinity of 230 nM 
for DRB1*03:01; this peptide probably uses an alternative binding register, with affinity 
comparable to the primary binding register, exploiting the D three amino acids to the left of the 
D>V mutation.  
 
Discussion 
The currently accepted paradigm for the event of peptide-MHC class II binding portrays the 
peptide lying flat in the peptide-binding groove of the MHC, extending out of both sides of the 
groove. The conformation of the peptide backbone is highly conserved, with a fixed distance of 
nine amino acids (the binding core) between the first and last peptide residue in contact with 
the MHC class II groove. This model is supported by a vast amount of literature and numerous 
crystal structures of peptide-MHC complexes (4,27), and has been tremendously useful to study 
the mechanisms of epitope presentation. While confirming that the great majority of peptides 
bind to the MHC using this canonical mode, in this work we report evidence for an alternative, 
less common mode of interaction. The basic idea is that a fraction of observed ligands have an 
unconventional spacing of the anchor residues that can only be accommodated to the canonical 
MHC motif with a more stretched out peptide backbone, if the anchors are closer to each other 
than expected, or by the peptide bulging out of the MHC groove, if the anchors are separated by 
too many residues. 
 
The first, indirect evidence for a non-canonical mode of binding comes from a machine learning 
benchmark on a large set of binding affinity data. Allowing the peptide binding core to take on a 
variable length of either eight, nine or ten residues, we showed that we could build models with 
significantly higher predictive performance compared to having a fixed binding core of nine 
contiguous amino acids. Because more accurate models should correspond to better 
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approximations of the biological system being modeled, these results suggest that such non-
canonical cores do occur in practice. These observations were also confirmed in a redundancy-
controlled setup, where we ensured that the improved accuracy was not an artifact of over-
fitting on highly similar sequences. 
 
Further evidence for the occurrence of the proposed non-canonical mode of binding was 
collected with a mutational study of four MHCII binders. These peptides were all predicted to 
contain a deletion (that is, a 10mer binding core). We showed that the binding measurements of 
the mutated peptides are only coherent with a mode of binding that involves a binding core of 
ten amino acids, and that a canonical 9mer binding core cannot accommodate the peculiar 
anchor spacing of these peptides. Taken all together, these results are strongly suggestive of a 
non-canonical mode of binding for MHCII ligands that, to be best of our knowledge, has never 
been described before. 
 
Recent advances in mass-spectrometry have enabled large-scale analyses of the collection of 
peptides naturally presented by MHC molecules in a particular cell line. These technologies have 
a tremendous potential as they can generate thousands of datapoints in a single experiment 
(see for instance refs (28,29)). However, since antigen presenting cells normally express 
multiple MHC isoforms, the MHC restriction of each ligand is generally not known and must be 
assigned, either with a predictor of binding to MHC or through unsupervised clustering (30). 
While most studies in this field have focused on MHC class I eluted ligands, reports of class II 
ligandomes have started to appear (e.g ref (31)). When sufficient and reliable MHCII ligandome 
data become available, and the issues of restriction assignment are confidently solved, it will be 
essential to investigate the presence of non-canonical binding also in MHCII natural ligands. 
Ultimately, crystal structures of peptide-MHC class II complexes displaying a bulged mode of 
binding would be highly desirable, both to further confirm the occurrence of non-canonical 
binders and to study their possible effect on the recognition by the T-cell receptor.  
 
The results described in this work were obtained using the fully automated NNAlign machine-
learning pipeline (32). NNAlign has been previously applied to generate models of protease 
cleavage (15), characterization of MHC class II binding motifs (33), and it forms the foundation 
for the state-of-the-art prediction algorithms NetMHC (9), NetMHCpan (10), NetMHCII (14) and 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
NetMHCIIpan (12). In all these examples, it has been proven capable of detecting subtle motifs 
in quantitative peptide data, and of generating powerful prediction models for several biological 
problems. In this work, NNAlign highlighted anomalies in the manner a fraction of ligands bind 
to the MHCII, and suggested a non-canonical mode of peptide-MHC binding that was later 
confirmed by experimental validation. However, its applications are not limited to the MHC 
system, and it can be readily employed to study other kinds of receptor-ligand interactions. 
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Figure Legends 
Figure 1: Correlation coefficient (average over 37 molecules) of the method versus the number of 
burn-in iterations used to prime the networks. Networks were trained in cross-validation with a 
maximum insertion length of one amino acid and a maximum deletion length of one amino acid. NoGap 
corresponds to the method trained without insertions and deletions. 
 
Figure 2: Correlation coefficient for methods trained with different deletion (d) and insertion (i) 
maximum lengths. The method with at most one deletion and one insertion (d=1;i=1) had significantly 
higher performance than the method without insertions/deletions (d=0;i=0) with higher PCC in 34/37 
molecules (p=10-7). It also outperformed d=1;i=0 on 34/37 molecules (p=10-7) and d=0;i=1 on 33/37 
(p=10-6) molecules.  Allowing longer deletions of up to 2 amino acids (d=2;i=1) does not significantly 
improve cross-validated performance compared to d=1;i=1 (p=0.32). All p-values were calculated with 
two-tailed binomial tests. 
 
Figure 3: Frequency of predicted binders containing deletions (black) and insertions (white) in 
the binding core using a burn-in of 100 iterations. While some molecules have over 10% of predicted 
binders with a non-canonical binding core (e.g. HLA-DRB3*01:01 and HLA-DRB5*01:01), others have no 
predicted binding cores with insertions or deletions (e.g. the mouse H-2 alleles). The figure was 
generated, for each allele, from the top 10% scoring peptides out of 100,000 natural random 15-mers. 
 
Figure 4: Percent of peptide-MHCs that must be removed to ensure no overlap between cross-
validation partitions, depending on the common-motif threshold N on the x-axis. Approximately the 
same number of peptides has to be removed (~14-15%) for N=6 to N=10, reflecting a possible bias in the 
procedures used to assay binding affinity with a sliding window over antigens of interest. 
 
Figure 5: Correlation coefficient (average over 37 molecules) as a function of the burn-in rate for 
networks trained on the low redundancy data set. Networks were trained in cross-validation with a 
maximum insertion length of one amino acid and a maximum deletion length of one amino acid. NoGap 
corresponds to the method trained without insertions and deletions. 
Figure 6: Predicted 9mer and 10mer binding cores for two DRB1*03:01 and two DRB5*01:01 
ligands. The non-canonical spacing of the anchor residues can only be accommodated with a deletion in 
the binding core, which is depicted here as a protrusion of the peptide chain at the predicted position of 
the deletion. Reference sequence logos are from NNAlign (15). 
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Tables 
Table 1: Measured IC50 binding affinity for four MHC class II ligands in their wild type (WT) and 
mutated variants.  
 
Peptide Mut MHC Pred IC50 
MYFHKRDMRLLSLAV WT DRB1*03:01 + 272 
MYFHKRVMRLLSLAV P7D>V DRB1*03:01 - 29300 
MYAHKRDMRLLSLAV P3F>A DRB1*03:01 - 1780 
MYFGKRDMRLLSLAV P4H>G DRB1*03:01 + 743 
MEFHKRDMRLLSLAV P2Y>E DRB1*03:01 + 124 
LQIIDKIDAAFKVAA WT DRB1*03:01 + 90 
LQIIDKIVAAFKVAA P8D>V DRB1*03:01 - 59
§ 
LQIADKIDAAFKVAA P4I>A DRB1*03:01 - 539 
LQIIRKIDAAFKVAA P5D>R DRB1*03:01 + 89 
LQAIDKIDAAFKVAA P3I>A DRB1*03:01 + 152 
RNVFDEVIPTAFKIG WT DRB5*01:01 + 37 
RNVRDEVIPTAFKIG P4F>R DRB5*01:01 - 652 
RNVFDEVIPTAFAIG P13K>A DRB5*01:01 - 666 
RNVFDEVIPTARKIG P12F>R DRB5*01:01 + 5 
RNEFDEVIPTAFKIG P3V>E DRB5*01:01 + 15 
ISFCNANPGLMKDVA WT DRB5*01:01 + 12 
ISKCNANPGLMKDVA P3F>K DRB5*01:01 - 522 
ISFCNANPGLMGDVA P12K>G DRB5*01:01 - 599 
ISFCNANPGLRKDVA P11M>R DRB5*01:01 + 0.2 
IEFCNANPGLMKDVA P2S>E DRB5*01:01 + 10 
 
Mutations are listed in the Mut column and highlighted in bold letters in the peptide. The predicted 
10mer binding core is underlined. Pred is the expected outcome if the peptide contained a 10mer binding 
core. § This mutant has a predicted secondary binding core (see text). 
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